This inventor holds 1 USPTO granted patent. Top assignee: Biomea Fusion, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Mini Balakrishnan: Innovator in GLP-1R Agonists
Introduction
Mini Balakrishnan is a prominent inventor based in San Mateo, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that activate GLP-1R pathways. Her work is crucial in addressing health issues such as diabetes and obesity.
Latest Patents
Mini Balakrishnan holds 1 patent for her invention titled "Heterocyclic GLP-1R agonists." This patent discloses heterocyclic compounds that activate GLP-1R pathways. Additionally, it includes pharmaceutical compositions that incorporate these compounds. The methods of using the GLP-1R agonists are also detailed, either alone or in combination with other therapeutic agents, for the treatment of diabetes, obesity, and other diseases or conditions dependent on GLP-1R pathways.
Career Highlights
Mini Balakrishnan is currently associated with Biomea Fusion, Inc., where she continues to innovate in the pharmaceutical sector. Her expertise in GLP-1R pathways positions her as a key player in the development of new therapeutic solutions.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Mini Balakrishnan's work in the field of GLP-1R agonists showcases her dedication to advancing medical science and improving patient outcomes. Her contributions are vital in the ongoing fight against diabetes and obesity.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile